Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00157716 · ClinicalTrials.gov registry record · Phase 2
MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)
A Phase 2 study, sponsored by Medicure.
- Completed
- Registry status
- Phase 2
- Development phase
- 900
- Enrollment target
NCT00157716: Completed Phase 2 study, sponsored by Medicure.
NCT00157716 is a Phase 2 study that has completed, run by Medicure. The registered enrollment target is 900 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (577% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00157716, a Phase 2 study, has completed, sponsored by Medicure.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 900 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether MC-1 is effective and safe in reducing cardiovascular and neurological events in patients undergoing high-risk coronary artery bypass surgery
Interventions
- DRUG (MC-1) Pyridoxal-5'-phosphate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 900 participants |
| Start Date | 2004-04 |
| Est. Completion | 2005-10 |
| Phase | Phase 2 |
What the finished NCT00157716 record still lists
NCT00157716 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (577% higher).
The record links to 0 conditions, and to 1 intervention - of which (MC-1) Pyridoxal-5'-phosphate is the first listed.
NCT00157716 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00157716 about?
NCT00157716 is a clinical study titled "MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)". The purpose of this study is to determine whether MC-1 is effective and safe in reducing cardiovascular and neurological events in patients undergoing high-risk coronary artery bypass surgery
What is the current status of trial NCT00157716?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 900 participants. The study started on 2004-04. Estimated completion is 2005-10.
What interventions are being tested in trial NCT00157716?
The interventions under investigation include: (MC-1) Pyridoxal-5'-phosphate (DRUG).
Who is sponsoring clinical trial NCT00157716?
This trial is sponsored by Medicure, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00157716's enrollment target sits among peer trials
900 30th of 2000 higher than 1,968 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
- NCT02414347 · 900 participants
F 18 T807 Tau PET Imaging of Alzheimer's Disease
- NCT02670408 · 900 participants
Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation
- NCT02960022 · 900 participants · Phase 2
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia